Current and historical daily PE Ratio for Apex Biotechnology Corp (
) from 2001 to Jun 11 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Apex Biotechnology stock (TPE:1733) PE ratio as of Jun 11 2024 is 30.73.
More Details
Apex Biotechnology Corp (TPE:1733) PE Ratio (TTM) Chart
Apex Biotechnology Corp (TPE:1733) PE Ratio (TTM) Historical Data
View and export this data going back to 2001. Start your Free Trial
Total 1212
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Apex Biotechnology PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-11 | 30.7 | 2024-04-03 | 31.6 |
| 2024-06-07 | 30.7 | 2024-04-02 | 31.2 |
| 2024-06-06 | 30.1 | 2024-04-01 | 31.3 |
| 2024-06-05 | 30.6 | 2024-03-29 | 31.1 |
| 2024-06-04 | 30.1 | 2024-03-28 | 31.5 |
| 2024-06-03 | 30.3 | 2024-03-27 | 29.1 |
| 2024-05-31 | 30.7 | 2024-03-26 | 28.8 |
| 2024-05-30 | 30.4 | 2024-03-25 | 29.4 |
| 2024-05-29 | 30.7 | 2024-03-22 | 29.3 |
| 2024-05-28 | 30.2 | 2024-03-21 | 29.3 |
| 2024-05-27 | 29.6 | 2024-03-20 | 29.5 |
| 2024-05-24 | 29.7 | 2024-03-19 | 29.4 |
| 2024-05-23 | 29.6 | 2024-03-18 | 29.1 |
| 2024-05-22 | 30.8 | 2024-03-15 | 27.5 |
| 2024-05-21 | 31.1 | 2024-03-14 | 27.8 |
| 2024-05-20 | 31.6 | 2024-03-13 | 26.9 |
| 2024-05-17 | 31.0 | 2024-03-12 | 27.3 |
| 2024-05-16 | 32.5 | 2024-03-11 | 26.9 |
| 2024-05-15 | 32.3 | 2024-03-08 | 27.2 |
| 2024-05-14 | 32.3 | 2024-03-07 | 27.7 |
| 2024-05-13 | 32.2 | 2024-03-06 | 28.0 |
| 2024-05-10 | 32.4 | 2024-03-05 | 27.8 |
| 2024-05-09 | 32.6 | 2024-03-04 | 28.1 |
| 2024-05-08 | 32.7 | 2024-03-01 | 28.4 |
| 2024-05-07 | 31.4 | 2024-02-29 | 28.9 |
| 2024-05-06 | 31.1 | 2024-02-27 | 29.1 |
| 2024-05-03 | 31.5 | 2024-02-26 | 29.8 |
| 2024-05-02 | 31.5 | 2024-02-23 | 28.7 |
| 2024-04-30 | 30.9 | 2024-02-22 | 29.2 |
| 2024-04-29 | 31.2 | 2024-02-21 | 29.5 |
| 2024-04-26 | 31.0 | 2024-02-20 | 29.7 |
| 2024-04-25 | 31.0 | 2024-02-19 | 29.8 |
| 2024-04-24 | 30.8 | 2024-02-16 | 29.7 |
| 2024-04-23 | 30.6 | 2024-02-15 | 29.2 |
| 2024-04-22 | 30.7 | 2024-02-09 | 28.1 |
| 2024-04-19 | 30.7 | 2024-02-08 | 28.1 |
| 2024-04-18 | 31.1 | 2024-02-07 | 28.1 |
| 2024-04-17 | 31.2 | 2024-02-06 | 28.1 |
| 2024-04-16 | 31.0 | 2024-02-05 | 28.1 |
| 2024-04-15 | 31.6 | 2024-02-02 | 28.1 |
| 2024-04-12 | 32.1 | 2024-02-01 | 29.1 |
| 2024-04-11 | 32.3 | 2024-01-31 | 28.7 |
| 2024-04-10 | 32.7 | 2024-01-30 | 28.5 |
| 2024-04-09 | 31.7 | 2024-01-29 | 28.0 |
| 2024-04-08 | 34.7 | 2024-01-26 | 28.1 |
Apex Biotechnology Corp (TPE:1733) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Apex Biotechnology Corp
ISIN : TW0001733004
Description
Apex Biotechnology Corp engages mainly in the research, development, production, manufacturing, and selling of biochemical testing instruments and detection strips, and the trade of products and components relevant to the core business. Its products offer Diabetes Care, Home Diagnostics, and Point-of-Care Clinical and Laboratory. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, and HemoSmart GOLD hemoglobin screening system among others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers